Thursday, September 29, 2005

Physicians Ill-prepared To Diagnose, Treat Bioterrorism Diseases

More than one-half of 631 physicians tested were unable to correctly diagnose diseases caused by agents most likely to be used by bioterrorists, such as smallpox, anthrax, botulism and plague, according to a Johns Hopkins study published in the Sept. 26 issue of Archives of Internal Medicine.

Related News Stories
Is Anthrax Just The Beginning? (October 19, 2001) -- Jim Matthews, an associate professor of pharmacy at Northeastern University's Bouvé College of Health Sciences, says that though the use of anthrax as a bioterrorist weapon is haunting, it is not ... > full story
Hopkins Center For Civilian Biodefense Studies Co-Sponsors Symposium On Medical/Public Health Response To Bioterrorism (February 10, 1999) -- With weapons of biological and chemical terrorism in the headlines and firmly on the nation's public agenda, political leaders, physicians, research scientists, as well as law enforcement and ... > full story
Balancing 'Hysteria And Suspicion': Doctors Face New Responsibilities In 'Bioterrorism Era' (December 27, 2004) -- The emergence of bioterrorism as a threat is creating new responsibilities for the medical community and, for the first time in history, is putting physicians at the forefront of managing disaster, ... > full story
FDA Approves New Plasma-derived Product To Treat Complications Of Smallpox Vaccination (March 3, 2005) -- The U.S. Food and Drug Administration has approved Vaccinia Immune Globulin Intravenous (VIGIV) -- the first intravenous human plasma-derived product available to treat certain rare complications of ... > full story
> more related stories
Related section:
Health & Medicine

However, test scores improved dramatically for the same physicians after they completed an online training course in diagnosing and managing these diseases caused by bioterrorism agents, according to the study.

"Most American physicians in practice today have never seen any cases of these diseases in their practice," explained Sara Cosgrove, M.D., M.S., a faculty member in Hopkins' Division of Infectious Diseases. "Preparation will be key to dealing with a major catastrophe, such as a major bioterrorist attack. Education and training healthcare providers in disease recognition, treatment and prevention strategies have the potential to significantly limit the effects of a bioterrorism attack."

In the study, 631 physicians at 30 internal medicine residency programs in 16 states and Washington, D.C. were tested on how to recognize and treat bioterrorism-related diseases before and after taking an online course in bioterrorism disease. On the pretest, correct diagnosis of diseases due to bioterrorism agents was smallpox, 50.7 percent; anthrax, 70.5 percent; botulism, 49.6 percent; and plague, 16.3 percent (average 46.8 percent), the researchers report. Correct diagnosis averaged 79.0 percent after completion of the course. Correct management of smallpox in the pretest was 14.6 percent; anthrax, 17.0 percent; botulism, 60.2 percent; and plague 9.7 percent (average 25.4 percent). Correct management averaged 79.1 percent after course completion.

Other Hopkins researchers involved in the study include Stephen Sisson, M.D., assistant professor of medicine; Trish Perl, M.D., M.Sc., associate professor of medicine and pathology and hospital epidemiologist; and Xiaoyan Song, M.D., assistant professor of medicine.
Editor's Note: The original news release can be found here.
-->
This story has been adapted from a news release issued by Johns Hopkins Medical Institutions.